Segment Information

12 Months Ended

Dec. 31, 2023

Segment Information

Segment Information

3. Segment Information

The Company operates in a single segment, which is the development and commercialization of human therapeutics. The following table summarizes total revenue by geographic region based on the location of the Company’s customers or collaboration partners:

	Year Ended December 31,
(In thousands)	2023		2022
US	$	57,201	$	51,124
Europe		223		222
Total revenue	$	57,424	$	51,346

The following table summarizes total revenue from each of the Company’s customers or collaboration partners who individually accounted for 10% or more of total revenue (as a percentage of total revenues) during the most recent three years:

	Year Ended December 31,
(% of total revenue)	2023		2022
Viatris	100	%	95	%

Viatris accounted for 100% of the Company’s receivable from collaborative arrangements as of December 31, 2023 and 2022.